Vimarsana
Biggest News Aggregation in the World

Technosphere Insulin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technosphere Insulin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technosphere Insulin Today - Breaking & Trending Today

MannKind Presents Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30 - Vimarsana News

MannKind Presents Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30

27.04.2022 - Simplified 2x dose of Technosphere Insulin (TI) produced a statistically significant improvement in PPGE between Dose 1 & 2 from 45-120 minutesHigher dose of TI resulted in a mean difference of 52 mg/dL in PPGE at 120 minutes, with no new safety ... Seite 1

MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population - Vimarsana News

MannKind Announces First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population

/PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients...

MannKind Announces Data Presentation At 14th International Conference On Advanced Technologies & Treatments For Diabetes (ATTD 2021) To Be Held Virtually June 2-5 - Vimarsana News

MannKind Announces Data Presentation At 14th International Conference On Advanced Technologies & Treatments For Diabetes (ATTD 2021) To Be Held Virtually June 2-5

/PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD), which focuses on the development of innovative medicines for patients with endocrine and orphan lung...